Observational, Non-interventional Use of LIPUS to Mitigate Fracture Non-union in Patients at Risk
Completed
Conditions studied: Mitigation of Fracture Non-union in Patients at Risk
In brief
This study is one of three separate studies of the Bioventus Observational Non-interventional EXOGEN Studies (BONES) program. Eligibility for each study is determined by fractured bone.
Key facts
- Study ID
- NCT03382483
- Run by
- Bioventus LLC
- People needed
- 12387
- Starts
- 2017-10-16
- Expected to finish
- 2022-05-01
- Last updated by the study team
- 2025-10-28
Who can join
Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Must be willing to provide voluntary informed consent
- Male or female age 21-80 on fracture date
- Must be willing to sign for release of medical insurance claim billing records from the treating clinician, pertaining to the fracture and fracture treatment
- Fluency in English and/or Spanish
- Prescriptive initiation of therapy with the EXOGEN Ultrasound Bone Healing System (Model number 71034400) for a specified fracture
- Bone specific fracture
You may not qualify if…
- Patient report of treatment with an electrical bone growth stimulation device (e.g., pulsed electromagnetic field (PEMF) or capacitive coupling (CC) based devices) for bone fracture in 9-months pre-index period up to baseline phone contact
- Pregnant on fracture index date
- Evidence that prescription for EXOGEN has been written to treat a fracture non-union or mal-union (i.e, ICD-10-CM code with seventh character modifier of K, P or S).
- Evidence that prescription for EXOGEN has been written to treat a pathologic fracture (ICD-10-CM code M80. or M84.) or neuropathic bone (ICD-10-CM code M14.6)
- Patient with a concurrent fracture of the other bones of interest
- Patients who are or anticipate living or receiving fracture treatment outside of the US during the post-index fracture period
- Patient report of history of primary or metastatic bone cancer
- Patient report of bone infection or osteomyelitis of index fracture at baseline contact
- Patient report of prior bone specific fracture in 9-months pre-index period
- Patient prescribed EXOGEN as part of a Worker Compensation claim
Where it is running
- CliniCallRN — Jericho, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.